Lineage Cell Therapeutics Inc Stock (LCTX) Financials Data
*All numbers in millions
| Period End Date | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 34.14%1.43 | 1.07 | 1.73 | 6.61 | 3.68 |
20.03%3.82 | 4.77 | 4.23 | - | - | |
| Research and Development | 20.03%3.82 | 4.77 | 4.23 | - | - |
| Costs And Expenses | 12.45%8.75 | 9.99 | 9.32 | 13.16 | 7.47 |
| Depreciation and Amortization | 8.02%0.20 | 0.19 | 0.19 | 0.19 | 0.18 |
| Operating Income/Loss | 18.03%-7.31 | -8.92 | -7.59 | -6.55 | -3.79 |
| Nonoperating Income/Loss | 14.91%12.03 | 10.47 | 2.80 | 2.16 | -25.97 |
| Income/Loss From Continuing Operations Before Tax | 4.71 | - | - | -4.39 | -29.75 |
| Income Tax Expense/Benefit | 0.48 | - | - | - | - |
173.96%4.23 | 1.54 | -4.79 | 0.89 | -29.75 | |
| Attributable To Parent | 185.56%4.23 | 1.48 | -4.81 | 0.85 | -29.78 |
| Available To Common Stockholders, Basic | 185.56%4.23 | 1.48 | -4.81 | 0.85 | -29.78 |
| Attributable To Noncontrolling Interest | 103.23%-0.00 | 0.06 | 0.02 | 0.04 | 0.03 |
| Basic Average Shares | 1.37%252.91 | 249.50 | 245.03 | 2.35 | 228.85 |
| Diluted Average Shares | 0.92%259.08 | 261.47 | 261.18 | 2.35 | 228.85 |
| Basic Earnings Per Share | 100.00%0.02 | 0.01 | -0.02 | - | -0.13 |
| Diluted Earnings Per Share | -0.03 | -0.03 | -0.03 | - | -0.13 |